Hereditary angioedema: Safety of long-term stanozolol therapy

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 3, 2007, Pages 654-658

  Sloane, David E ^a   Lee, Chyh Woei ^a   Sheffer, Albert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

attenuated androgens; Hereditary angioedema; side effects; stanozolol

Indexed keywords

STANOZOLOL;

ACNE; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LONG TERM CARE; MALE; MENORRHAGIA; MENSTRUAL IRREGULARITY; MOOD CHANGE; OLIGOMENORRHEA; PHYSICAL EXAMINATION; POSTMENOPAUSE BLEEDING; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; ANGIONEUROTIC EDEMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STANOZOLOL;

EID: 34548261373     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.06.037     Document Type: Article

References (15)

1. Spaulding W. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53 (1960) 139-145
2. Sheffer A.L., Fearon D.T., and Austen K.F. Methyltestosterone therapy in hereditary angioedema. Ann Intern Med 86 (1977) 306-308
3. Gelfand J.A., Sherins R.J., Alling D.W., and Frank M.M. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med 295 (1976) 1444-1448
4. Sheffer A.L., Fearon D.T., and Austen K.F. Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema. J Allergy Clin Immunol 64 (1979) 275-280
5. Agostoni A., Cicardi M., Martignoni G.C., Bergamaschini L., and Marasini B. Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J Allergy Clin Immunol 65 (1980) 75-79
6. Farrell G.C., Joshua D.E., Uren R.F., Baird P.J., Perkins K.W., and Kronenberg H. Androgen-induced hepatoma. Lancet 1 (1975) 430-432
7. Johnson F.L., Lerner K.G., Siegel M., Feagler J.R., Majerus P.W., Hartmann J.R., et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2 (1972) 1273-1276
8. Cicardi M., Castelli R., Zingale L.C., and Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 99 (1997) 194-196
9. Sheffer A.L., Fearon D.T., and Austen K.F. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J Allergy Clin Immunol 68 (1981) 181-187
10. Sheffer A.L., Fearon D.T., and Austen K.F. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol 80 (1987) 855-860
11. Bork K., Pitton M., Harten P., and Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 353 (1999) 1066-1067
12. Bowen T., Cicardi M., Farkas H., Bork K., Kreuz W., Zingale L., et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114 (2004) 629-637
13. Prematta M., Gibbs J.G., Pratt E.L., Stoughton T.R., and Craig T.J. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 98 (2007) 383-388
14. Cicardi M., Bergamaschini L., Tucci A., Agostoni A., Tornaghi G., Coggi G., et al. Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol 72 (1983) 294-298
15. Zurlo J.J., and Frank M.M. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 54 (1990) 64-72